Researchers report possible HIV infection cure; others cite dangers

Henk Elegeert h.elegeert at GMAIL.COM
Wed Dec 15 08:07:26 CET 2010


REPLY TO: D66 at nic.surfnet.nl

   Researchers report having cured patient of
#HIV<file:///search%3Fq=%2523HIV>infection
   http://on.cnn.com/e2NVYE

"
Researchers report possible HIV infection cure; others cite
dangers<http://edition.cnn.com/2010/HEALTH/12/14/hiv.infection.cure/index.html>
By *Tom Watkins*, CNN
December 15, 2010 -- Updated 0346 GMT (1146 HKT)
[image: Demonstrators march in Vienna, Austria, as part of the 18th
International AIDS Conference on July 20, 2010.]
Demonstrators march in Vienna, Austria, as part of the 18th International
AIDS Conference on July 20, 2010.
*STORY HIGHLIGHTS*

   - A Berlin man has been off anti-AIDS medication for 3-1/2 years
   - But the stem-cell transplant credited for ridding him of HIV is costly,
   dangerous
   - "This is probably a cure, but it comes at a bit of a price," says one
   AIDS doctor

*(CNN)* -- Researchers in Germany are reporting that they may have cured a
man of HIV infection. If true, that would represent a scientific advance,
but not necessarily a treatment advance, said researchers familiar with the
work.

In the study, published last week online in the journal Blood, researchers
at Charite-University Medicine Berlin treated an HIV-infected man who also
had acute myeloid leukemia -- a cancer of the immune system -- by wiping out
his own immune system with high-dose chemotherapy and radiation and giving
him a stem-cell transplant. Stem cells are immature cells that can mature
into blood cells.

At the time of the transplant, which occurred in February 2007, he stopped
taking anti-HIV medications.

Thirteen months later, after a relapse of the leukemia, he underwent a
second round of treatment followed by another stem-cell transplant from the
same donor.

The donor's stem cells contained a rare, inherited gene mutation that made
them naturally resistant to infection with HIV, according to the authors,
led by Kristina Allers, who hypothesized that HIV would nevertheless rebound
over time. But that has not happened.

After three-and-a-half years off of anti-HIV drugs, the patient shows no
sign of either leukemia or HIV replication and his immune system has been
restored to normal health, the researchers reported, concluding, "our
results strongly suggest that cure of HIV has been achieved in this
patient."

But AIDS researchers predicted the report will have little impact on
practice.

"This probably is a cure, but it comes at a bit of a price," said Dr.
Michael Saag, professor of medicine and director of the University of
Alabama at Birmingham AIDS Center.

"For him to receive the donor cells, his body had to have all of his immune
system wiped out" and then receive a bone marrow transplant, Saag noted.
"The Catch-22 here is that the best candidates for a cure, ideally, are
people who are healthy" and don't have leukemia.

The treatment associated with wiping out the immune system "is very
hazardous," he said in a telephone interview.

"Even if somebody doesn't die from a transplant, there are complications
that make it very unpleasant for people to live with," he said, citing
graft-versus-host disease, where the infused donor cells attack the body. In
a number of cases, the transplant proves fatal.

The study is a proof of the concept "that our understanding of HIV biology
is correct, and that if you eliminate -- not just in theory but in practice
-- all of the cells in the body that are producing HIV and replace them with
uninfected cells, you have a cure," Saag said.

But remaining infected with HIV is not always associated with the same grim
outcome that was the norm prior to the mid-1990s, when more effective
anti-HIV drugs were developed, he said.

"We can keep people alive for a normal life span," he said. "That means a
25-year-old diagnosed today with HIV has a reasonably good chance of living
to 80, 85, 90."

Further limiting the treatment's potential appeal is the fact that it could
cost hundreds of thousands of dollars for each patient who gets it, he said.

"It's not going to be applicable unless they develop leukemia or lymphoma
and need a bone-marrow transplant,"Saag said.

Dr. Anthony Fauci, director of the National Institute of Allergy and
Infectious Diseases, called it impractical. "It's hard enough to get a good
compatible match for a transplant like this," he said in a statement. "But
you also have to find (a) compatible donor that has this genetic defect, and
this defect is only found in 1% of the Caucasian population and 0% of the
black population. This is very rare."

But HIV itself is not. According to the World Health Organization, 33.4
million people worldwide have the virus that causes AIDS.

"

**********
Dit bericht is verzonden via de informele D66 discussielijst (D66 at nic.surfnet.nl).
Aanmelden: stuur een email naar LISTSERV at nic.surfnet.nl met in het tekstveld alleen: SUBSCRIBE D66 uwvoornaam uwachternaam
Afmelden: stuur een email naar LISTSERV at nic.surfnet.nl met in het tekstveld alleen: SIGNOFF D66
Het on-line archief is te vinden op: http://listserv.surfnet.nl/archives/d66.html
**********



More information about the D66 mailing list